Luminex Shares Outstanding 2006-2020 | LMNX

Luminex shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Luminex Annual Shares Outstanding
(Millions of Shares)
2019 44
2018 44
2017 43
2016 43
2015 43
2014 42
2013 42
2012 42
2011 43
2010 42
2009 42
2008 40
2007 34
2006 33
2005 31
Luminex Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 45
2019-12-31 44
2019-09-30 44
2019-06-30 44
2019-03-31 45
2018-12-31 44
2018-09-30 45
2018-06-30 44
2018-03-31 44
2017-12-31 43
2017-09-30 43
2017-06-30 43
2017-03-31 43
2016-12-31 43
2016-09-30 43
2016-06-30 43
2016-03-31 42
2015-12-31 43
2015-09-30 43
2015-06-30 42
2015-03-31 42
2014-12-31 42
2014-09-30 42
2014-06-30 42
2014-03-31 42
2013-12-31 42
2013-09-30 42
2013-06-30 41
2013-03-31 41
2012-12-31 42
2012-09-30 42
2012-06-30 42
2012-03-31 43
2011-12-31 43
2011-09-30 43
2011-06-30 42
2011-03-31 42
2010-12-31 42
2010-09-30 41
2010-06-30 42
2010-03-31 42
2009-12-31 42
2009-09-30 41
2009-06-30 41
2009-03-31 40
2008-12-31 40
2008-09-30 42
2008-06-30 36
2008-03-31 35
2007-12-31 34
2007-09-30 35
2007-06-30 35
2007-03-31 33
2006-12-31 33
2006-09-30 33
2006-06-30 33
2006-03-31 32
2005-12-31 31
2005-09-30 31
2005-06-30 31
2005-03-31 31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.489B $0.335B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $151.096B 30.68
Intuitive Surgical (ISRG) United States $67.157B 49.60
Edwards Lifesciences (EW) United States $42.026B 35.32
DexCom (DXCM) United States $40.599B 189.50
IDEXX Laboratories (IDXX) United States $28.729B 67.65
ALCON INC (ALC) Switzerland $27.774B 31.09
Fresenius Medical Care AG KGaA (FMS) Germany $25.352B 17.27
Olympus (OCPNY) Japan $25.252B 51.36
Teleflex (TFX) United States $16.471B 30.51
Sysmex ADR (SSMXY) Japan $15.461B 43.58
Hologic (HOLX) United States $14.897B 23.45
SONOVA HOLDING (SONVY) Switzerland $13.774B 0.00
STERIS (STE) Ireland $12.786B 26.69
Masimo (MASI) United States $12.508B 67.98
ABIOMED (ABMD) United States $11.915B 63.89
Varian Medical Systems (VAR) United States $10.800B 26.19
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.730B 259.28
Tandem Diabetes Care (TNDM) United States $6.176B 0.00
Globus Medical (GMED) United States $4.473B 28.30
Integra LifeSciences Holdings (IART) United States $3.944B 18.09
Nevro (NVRO) United States $3.879B 0.00
Wright Medical Group (WMGI) Netherlands $3.851B 597.60
Elekta AB (EKTAY) Sweden $3.564B 27.44
OPKO Health (OPK) United States $2.693B 0.00
Nihon Kohden (NHNKY) Japan $2.686B 0.00
LivaNova (LIVN) United Kingdom $2.502B 18.87
Integer Holdings (ITGR) United States $2.182B 13.48
Cantel Medical (CMD) United States $1.901B 22.00
Glaukos (GKOS) United States $1.679B 0.00
Veracyte (VCYT) United States $1.452B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.426B 27.64
Silk Road Medical (SILK) United States $1.416B 0.00
ShockWave Medical (SWAV) United States $1.377B 0.00
GenMark Diagnostics (GNMK) United States $1.079B 0.00
Mesa Laboratories (MLAB) United States $0.967B 51.16
Accelerate Diagnostics (AXDX) United States $0.921B 0.00
Inogen (INGN) United States $0.785B 46.85
OrthoPediatrics (KIDS) United States $0.759B 0.00
Natus Medical (NTUS) United States $0.715B 17.63
Tactile Systems Technology (TCMD) United States $0.693B 87.85
CryoLife (CRY) United States $0.689B 96.05
Quotient (QTNT) Switzerland $0.613B 0.00
Intersect ENT (XENT) United States $0.588B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.579B 23.36
Pacific Biosciences Of California (PACB) United States $0.573B 0.00
Si-Bone (SIBN) United States $0.446B 0.00
AxoGen (AXGN) United States $0.434B 0.00
Repro-Med Systems (KRMD) United States $0.420B 322.00
Fluidigm (FLDM) United States $0.414B 0.00
AngioDynamics (ANGO) United States $0.380B 25.25
TransMedics (TMDX) United States $0.360B 0.00
Vermillion (AWH) United States $0.345B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.337B 0.00
ViewRay (VRAY) United States $0.323B 0.00
Semler Scientific (SMLR) United States $0.304B 33.51
IRadimed (IRMD) United States $0.285B 30.73
Alphatec Holdings (ATEC) United States $0.285B 0.00
SeaSpine Holdings (SPNE) United States $0.261B 0.00
RTI Surgical (RTIX) United States $0.218B 0.00
Sientra (SIEN) United States $0.202B 0.00
Accuray (ARAY) United States $0.187B 0.00
T2 Biosystems (TTOO) United States $0.165B 0.00
Restoration Robotics (VERO) Canada $0.099B 0.00
Spectral Diagnostics (EDTXF) Canada $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.071B 35.14
Ekso Bionics Holdings (EKSO) United States $0.067B 0.00
ConforMIS (CFMS) United States $0.060B 0.00
Bioanalytical Systems (BASI) United States $0.054B 0.00
MRI Interventions (CLPT) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.047B 0.00
Allied Healthcare Products (AHPI) United States $0.044B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.043B 0.00
Neuronetics (STIM) United States $0.037B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.035B 0.00
Apollo Endosurgery (APEN) United States $0.032B 0.00
Neovasc (NVCN) Canada $0.026B 0.00
DarioHealth (DRIO) Israel $0.026B 0.00
Delcath Systems (DCTH) United States $0.025B 0.00
Sunshine Heart Inc (CHFS) United States $0.024B 0.00
Second Sight Medical Products (EYES) United States $0.021B 0.00
Helius Medical Technologies (HSDT) United States $0.020B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.011B 0.00
Avinger (AVGR) United States $0.010B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Nanovibronix (NAOV) United States $0.008B 0.00
Ra Medical Systems (RMED) United States $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00